| The PD1: PD-L1/2 pathway from discovery to clinical implementation K Bardhan, T Anagnostou, VA Boussiotis Frontiers in immunology 7, 218368, 2016 | 561 | 2016 |
| Molecular and nonmolecular diagnostic methods for invasive fungal infections M Arvanitis, T Anagnostou, BB Fuchs, AM Caliendo, E Mylonakis Clinical microbiology reviews 27 (3), 490-526, 2014 | 367 | 2014 |
| Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels D Tian, SMP Jacobo, D Billing, A Rozkalne, SD Gage, T Anagnostou, ... Science signaling 3 (145), ra77-ra77, 2010 | 294 | 2010 |
| T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood LA Neely, M Audeh, NA Phung, M Min, A Suchocki, D Plourde, M Blanco, ... Science translational medicine 5 (182), 182ra54-182ra54, 2013 | 279 | 2013 |
| Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature T Anagnostou, M Arvanitis, TK Kourkoumpetis, A Desalermos, ... Medicine 93 (1), 19-32, 2014 | 175 | 2014 |
| Fusarium infection: report of 26 cases and review of 97 cases from the literature M Muhammed, T Anagnostou, A Desalermos, TK Kourkoumpetis, ... Medicine 92 (6), 305-316, 2013 | 174 | 2013 |
| Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis T Anagnostou, IB Riaz, SK Hashmi, MH Murad, SS Kenderian The Lancet Haematology 7 (11), e816-e826, 2020 | 113 | 2020 |
| Galactomannan and polymerase chain reaction–based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis M Arvanitis, T Anagnostou, E Mylonakis Clinical Infectious Diseases 61 (8), 1263-1272, 2015 | 103 | 2015 |
| The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU setting: a meta-analysis of published studies PD Ziakas, T Anagnostou, E Mylonakis Critical care medicine 42 (2), 433-444, 2014 | 80 | 2014 |
| Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience AK Omer, PD Ziakas, T Anagnostou, E Coughlin, T Kourkoumpetis, ... Biology of Blood and Marrow Transplantation 19 (8), 1190-1196, 2013 | 79 | 2013 |
| Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy R Shouval, A Alarcon Tomas, JA Fein, JR Flynn, E Markovits, S Mayer, ... Journal of clinical oncology 40 (4), 369-381, 2022 | 76 | 2022 |
| Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors RK Leaf, C Ferreri, D Rangachari, J Mier, W Witteles, G Ansstas, ... American journal of hematology 94 (5), 563-574, 2019 | 62 | 2019 |
| The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center M Arvanitis, T Anagnostou, TK Kourkoumpetis, PD Ziakas, A Desalermos, ... PloS one 9 (2), e89984, 2014 | 45 | 2014 |
| High progression-free survival after intermediate intensity double unit cord blood transplantation in adults JN Barker, SM Devlin, KA Naputo, K Skinner, MA Maloy, L Flynn, ... Blood advances 4 (23), 6064-6076, 2020 | 34 | 2020 |
| The PD1: PD-L1/2 pathway from discovery to clinical implementation. Front Immunol. 2016; 7: 550 K Bardhan, T Anagnostou, VA Boussiotis Epub 2016/12/27. https://doi. org/10.3389/fimmu. 2016.00550 PMID: 28018338, 2016 | 27 | 2016 |
| Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma A Alarcon Tomas, JA Fein, S Fried, JR Flynn, SM Devlin, WB Fingrut, ... Leukemia 37 (1), 154-163, 2023 | 25 | 2023 |
| Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia AA Mangaonkar, KK Reichard, M Binder, G Coltro, TL Lasho, RM Carr, ... Blood Advances 4 (21), 5425-5430, 2020 | 19 | 2020 |
| T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 5: 182ra54 LA Neely, M Audeh, NA Phung, M Min, A Suchocki, D Plourde, M Blanco, ... | 14 | 2013 |
| Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives T Anagnostou, MR Litzow Blood and Lymphatic Cancer: Targets and Therapy, 1-9, 2017 | 13 | 2017 |
| Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: a multicenter observational study AA Tomas, JA Fein, S Fried, W Fingrut, T Anagnostou, A Alperovich, ... Blood 138, 883, 2021 | 12 | 2021 |
